SEC FORM
4
SEC Form 4
FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0287 |
Estimated average burden |
hours per response: |
0.5 |
|
|
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
1. Name and Address of Reporting Person*
C/O INVIVO THERAPEUTICS HOLDINGS CORP. |
ONE BROADWAY, 14TH FLOOR |
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
INVIVO THERAPEUTICS HOLDINGS CORP.
[ NVIV ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X |
Director |
X |
10% Owner |
X |
Officer (give title below) |
|
Other (specify below) |
CEO, CFO |
|
3. Date of Earliest Transaction
(Month/Day/Year) 12/28/2011
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
Amount |
(A) or (D) |
Price |
COMMON STOCK, $0.00001 PAR VALUE |
12/28/2011 |
|
S |
|
143,500 |
D |
$2.7362
|
15,004,160 |
D |
|
COMMON STOCK, $0.00001 PAR VALUE |
11/29/2011 |
|
S |
|
95,000 |
D |
$2.516
|
14,909,160 |
D |
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Explanation of Responses: |
|
/S/ ELIZABETH FRASER, AS ATTORNEY IN FACT |
12/30/2011 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Power of Attorney
Power of Attorney
I, Frank Reynolds, the undersigned, hereby constitute and appoint Bradley Jacobson, Robert Puopolo,
Elizabeth Fraser, and Abdullah Malik, and each of them individually, as my true and lawful
attorney-in-fact to:
1. Complete and execute on my behalf, as an officer and/or director of InVivo Therapeutics
Holdings Corp., a Nevada corporation (the Company), Forms 3, 4, or 5 required to be filed
by me under Section 16(a) of the Securities Exchange Act of 1934, as amended (the Exchange
Act) and the rules and regulations thereunder;
2. Do and perform any and all acts for and on my behalf which may be necessary or desirable to
complete and execute any such Forms 3, 4 or 5 and timely file such forms with the U.S. Securities
and Exchange Commission and any stock exchange or similar authority; and
3. Take any other action of any type whatsoever in connection with the foregoing, which in the
opinion of such attorney-in-fact may be of benefit to, in the best interest of, or legally required
of me, it being understood that the documents executed by such attorney-in-fact on my behalf
pursuant to this Power of Attorney shall be in such form and shall contain such information as such
attorney-in-fact may approve in such attorney-in-facts discretion.
I hereby grant to each of such attorneys-in-fact full power and authority to do and perform all and
every act which is necessary, proper or desirable to be done in the exercise of any of the rights,
powers and authority granted in this Power of Attorney, with full power of substitution and
revocation, and I ratify and confirm every act that such attorney-in-fact lawfully performs or
causes to be done by virtue of this Power of Attorney and the powers and authority granted herein.
I acknowledge that the attorneys-in-fact appointed in this Power of Attorney, in serving in such
capacity at my request, are not assuming, and the Company is not assuming, any of my
responsibilities to comply with Section 16 of the Exchange Act or the rules or regulations
thereunder.
This Power of Attorney shall remain in full force and effect until I am no longer required to file
Forms 3, 4 or 5 with respect to my holdings or transactions in securities issued by the Company,
unless I earlier revoke this Power of Attorney in a signed writing delivered to the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of December 29th, 2011.
/s/ Frank Reynolds
Print Name: Frank Reynolds